查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1808303

醫療保健分析測試服務市場（按測試類型、技術類型、樣本類型、應用和最終用戶分類）—2025 年至 2030 年全球預測

Healthcare Analytical Testing Services Market by Testing Type, Technology Type, Sample Type, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計醫療分析測試服務市場規模到 2024 年將達到 92.8 億美元，到 2025 年將達到 103 億美元，到 2030 年將達到 177.9 億美元，複合年成長率為 11.44%。

主要市場統計數據
基準年2024年 92.8億美元
預計2025年 103億美元
預測年份 2030 177.9億美元
複合年成長率（%） 11.44%

探索醫療保健分析測試服務的發展動態以及影響未來市場發展的新需求促進因素

醫療保健分析檢測服務是現代醫學診斷、藥物研發和法醫學調查的基石。隨著臨床實驗室、受託研究機構和學術機構努力滿足日益嚴格的品質標準，對複雜調查方法的需求也日益成長。這些服務涵蓋了一系列旨在檢測、定量和表徵臨床樣本中生物和化學因子的技術。透過確保準確性、可重複性和合規性，分析檢測能夠保障病人安全，支持實證決策，並推動整個醫療保健領域的創新。

透過技術創新和不斷變化的監管環境，揭示重新定義醫療保健檢測格局的重大變革

在樣本處理、分析儀器和生物資訊學領域取得突破的推動下，醫療保健分析檢測生態系統正在經歷一場變革性的復興。隨著實驗室不斷追求更高的靈敏度和特異性，微流體平台和自動化樣品處理系統的採用正在擴大操作通量，同時減少樣品量和試劑浪費。這種模式轉移使實驗室能夠快速應對疫情，以前所未有的精度監測治療性生物標記物，並即時支持藥物動力學研究。

評估2025年美國關稅對醫療分析測試成本結構和營運策略的綜合累積影響

2025年，美國修訂後的關稅生效，為醫療分析檢測供應商及其供應鏈帶來了新的複雜性。來自主要製造地的多種關鍵試劑、儀器組件和專用耗材的成本正在逐步上漲。這些調整對單點實驗室和多點實驗室網路的服務定價模式、營運預算和資本支出計畫產生了下游影響。此外，其對全球經銷商的連鎖反應使其必須重新評估庫存策略，以降低關稅波動帶來的風險。

揭示醫療保健分析測試在測試類型、技術、樣本、應用程式和最終用戶方面的關鍵細分趨勢

醫療保健分析測試可以透過測試類型來理解。定性服務包括旨在快速目測或比色反應的抽檢測試，以及用於確認樣品完整性的詳細目視檢測通訊協定。相較之下，定量服務則依賴免疫測量來定量高特異性的生物標記物，並利用儀器分析技術利用光譜訊號和質荷比進行精確的濃度測量。這種雙重方法既能確保即時的篩檢能力，又能確保全面的定量檢驗。

介紹美洲、歐洲、中東和非洲以及亞太地區醫療分析測試市場動態的關鍵區域見解

區域動態在塑造全球醫療保健分析檢測格局方面發揮關鍵作用，因為不同地區不斷變化的法律規範、基礎設施能力和投資模式存在顯著差異。拉丁美洲的新興經濟體正優先考慮實驗室能力的擴展和技能的培養，以加強公共衛生監測網路。

重點介紹推動全球醫療分析測試服務創新的主要企業的策略性舉措和競爭格局

醫療保健分析檢測服務領域由許多知名實驗室、創新服務供應商和專業技術供應商組成。領先的開發商憑藉整合高通量篩檢、先進生物資訊學和客製化檢測開發等技術的綜合服務組合，脫穎而出。這些先驅企業對專有試劑組、實驗室自動化和數位資料平台的策略性投資，使其能夠提供標準化且靈活的解決方案，滿足廣泛的臨床和研究應用頻譜。

向行業領導者提供可行的建議，以加強競爭並推動醫療分析測試服務的成長。

產業領導者必須優先投資數位轉型，以保持競爭優勢和營運效率。整合雲端基礎的資料管理、人工智慧分析和遠端監控功能，可顯著縮短週轉時間，增強可追溯性，並支援可擴展的實驗室網路。與軟體開發人員和生物資訊學專家建立夥伴關係，可以將新興技術無縫融入現有工作流程。

詳細闡述了用於全面分析醫療分析測試服務趨勢和市場促進因素的嚴格調查方法

本分析的研究基礎是透過系統性的多階段方法建立的，包括收集一手和二手研究資料、嚴格的檢驗通訊協定以及專家諮詢。首先，進行了廣泛的文獻綜述，包括同行評審日誌、監管指南和行業白皮書，以了解基本趨勢並識別新興技術。這一二次研究階段為假設的生成和框架的發展奠定了基礎。

綜合關鍵發現和策略要點，幫助相關人員應對不斷發展的醫療分析測試服務格局

技術創新、不斷變化的監管環境以及不斷變化的經濟壓力正在重塑醫療保健分析檢測服務格局。從先進儀器的採用到數據工作流程的數位化，清楚地理解這些變革的相關人員將能夠抓住新機會，應對複雜的市場環境。 2025 年的關稅調整凸顯了韌性供應鏈和協作籌資策略對於緩解成本波動和維持利潤率的重要性。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 將人工智慧和機器學習演算法整合到臨床診斷測試中，以提高準確性和速度
  • 引入與數位健康生態系統整合的就地檢驗設備，用於即時病患監測
  • 個人化醫療的成長將推動對高通量基因組和蛋白質組檢測平台的需求
  • 監理機關越來越重視實驗室資訊管理系統對 21 CFR Part 11 的合規性
  • 增加代謝體學分析的投資，用於早期疾病生物標記的發現和預防性醫療保健策略
  • 擴大合約開發和製造組織，提供端到端分析方法開發服務
  • 實施區塊鏈技術，確保臨床試驗樣本和測試結果的安全可追溯性
  • 質譜成像在組織分析中快速應用於空間代謝體學和生物標記定位
  • 需要提供跨基因組學、蛋白質組學和代謝體學資料集的全面見解的多體學數據整合平台
  • 透過開發綠色化學分析方法來減少危險試劑的消耗，並專注於永續性

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8.醫療保健分析測試服務市場（按測試類型）

  • 定性
    • 抽查
    • 目視檢查
  • 定量
    • 免疫檢測
    • 儀器分析

9.醫療保健分析測試服務市場（依技術類型）

  • 層析法
    • 氣相層析法
    • 液相層析法
  • 質譜法
    • GC-MS
    • LC MS MS
    • MALDI TOF
  • 顯微鏡
  • PCR
  • 光譜學

第 10 章：醫療保健分析測試服務市場（按樣本類型）

  • 血
    • 電漿
    • 血清
    • 全血
  • 組織
  • 尿

第 11 章醫療保健分析測試服務市場（按應用）

  • 臨床診斷
    • 基因檢測
    • 感染疾病
    • 腫瘤標記
  • 刑事鑑定
    • DNA分析
    • 毒理學
  • 藥物測試
    • 生物分析測試
    • 品管

第 12 章：醫療保健分析測試服務市場（按最終用戶）

  • 學術研究機構
    • 研究機構
    • 大學
  • 合約研究組織
  • 醫院和診所
    • 醫院檢查室
    • 病理實驗室
  • 製藥和生物技術公司

13.美洲醫療保健分析實驗室服務市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 歐洲、中東和非洲醫療保健分析實驗室服務市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

15.亞太醫療保健分析實驗室服務市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第16章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Eurofins Scientific SE
    • Laboratory Corporation of America Holdings
    • Almac Group Limited
    • ALS Limited
    • Catalent, Inc.
    • CD Biosciences Inc.
    • Charles River Laboratories International, Inc.
    • Element Materials Technology Group Limited
    • Frontage Laboratories, Inc. by Tigermed
    • ICON PLC
    • Intertek Group PLC
    • IQVIA Holdings Inc.
    • Medpace, Inc.
    • Pace Analytical Services, LLC
    • Pharmaron
    • Piramal Pharma Solutions
    • PPD, Inc.
    • Quest Diagnostics Incorporated
    • Reading Scientific Services Ltd.
    • Sartorius AG
    • SGS SA
    • Thermo Fisher Scientific Inc.
    • WuXi AppTec Co., Ltd.

第17章 研究人工智慧

第18章 研究統計

第19章 研究聯絡人

第20章 研究報導

第21章 附錄

Product Code: MRR-F949FCDE0EC4

The Healthcare Analytical Testing Services Market was valued at USD 9.28 billion in 2024 and is projected to grow to USD 10.30 billion in 2025, with a CAGR of 11.44%, reaching USD 17.79 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 9.28 billion
Estimated Year [2025] USD 10.30 billion
Forecast Year [2030] USD 17.79 billion
CAGR (%) 11.44%

Exploring the Evolving Dynamics of Healthcare Analytical Testing Services and the Emerging Demand Drivers Shaping Future Market Developments

Healthcare analytical testing services serve as the cornerstone of modern medical diagnostics, pharmaceutical development, and forensic investigations. As clinical laboratories, contract research organizations, and academic institutions strive to meet increasingly stringent quality standards, the demand for sophisticated testing methodologies has surged. These services encompass a wide array of techniques designed to detect, quantify, and characterize biological and chemical agents in clinical samples. By ensuring accuracy, reproducibility, and regulatory compliance, analytical testing underpins patient safety, supports evidence-based decision-making, and fuels innovation across the healthcare continuum.

Over the past decade, the industry has witnessed a profound evolution driven by technological breakthroughs such as high-resolution mass spectrometry, advanced chromatography platforms, and next-generation sequencing. These innovations have not only expanded the scope of detectable analytes but also accelerated turnaround times, enabling real-time monitoring of biomarkers and therapeutic agents. Furthermore, the integration of digital data management solutions has enhanced traceability, data integrity, and collaborative research efforts. As a result, stakeholders are now better equipped to address complex clinical questions, optimize treatment protocols, and advance personalized medicine initiatives.

In this context, the investment landscape has adapted to foster strategic partnerships between equipment manufacturers, reagent suppliers, and service providers. Such collaborations are fostering the development of end-to-end solutions that streamline sample preparation, analysis, and reporting. This introduction establishes the foundational context for understanding the multifaceted dynamics shaping the healthcare analytical testing sector, setting the stage for a deeper exploration of transformative shifts, regulatory influences, and strategic imperatives.

Uncovering the Major Transformative Shifts Redefining Healthcare Testing Landscapes Through Technological Innovation and Regulatory Advancements

The healthcare analytical testing ecosystem is undergoing a transformative renaissance fueled by breakthroughs in sample processing, analytical instrumentation, and bioinformatics. As laboratories pursue heightened sensitivity and specificity, the adoption of microfluidic platforms and automated sample handling systems has scaled operational throughput while reducing sample volumes and reagent waste. This paradigm shift is empowering laboratories to respond swiftly to outbreaks, monitor therapeutic biomarkers with unprecedented precision, and support pharmacokinetic studies in real time.

Concurrently, the convergence of analytical testing with digital health technologies is redefining stakeholder interactions. Cloud-based data repositories, artificial intelligence-driven analysis pipelines, and blockchain-enabled chain-of-custody solutions are gradually becoming integral components of testing workflows. These digital overlays not only enhance transparency and collaboration between clinicians, researchers, and regulatory bodies but also enable remote assay validation and inter-laboratory proficiency testing on a global scale.

Regulatory landscapes have also adapted to accelerate the validation and deployment of novel analytical methodologies. Agencies are progressively endorsing risk-based approaches, real-world performance data, and harmonized validation protocols, enabling faster time-to-market for critical diagnostic assays. Moreover, the rising emphasis on sustainability has prompted vendors to innovate eco-friendly consumables and energy-efficient instrumentation.

Taken together, these technological, regulatory, and sustainability-driven shifts are reshaping the competitive landscape, compelling traditional players to forge alliances with digital innovators and bioinformatics specialists. This convergence underscores the imperative for laboratories and service providers to embrace end-to-end digital transformation and partner with ecosystem collaborators to maintain strategic relevance.

Assessing the Comprehensive Cumulative Impact of 2025 United States Tariffs on Healthcare Analytical Testing Cost Structures and Operational Strategies

In 2025, the implementation of revised United States tariffs has introduced a new layer of complexity for healthcare analytical testing providers and their supply chains. Several key reagents, instrumentation components, and specialty consumables sourced from major manufacturing hubs have experienced incremental cost escalations. These adjustments have downstream effects on service pricing models, operating budgets, and capital expenditure plans for both single-site laboratories and multi-site networks. Furthermore, the ripple effects on global distributors have necessitated the reevaluation of inventory strategies to mitigate exposure to tariff fluctuations.

Laboratories reliant on imported chromatography columns, mass spectrometry source components, and specialty solvents have reported extended negotiation cycles with suppliers to secure favorable terms amidst ongoing trade tensions. To preserve margin integrity, many service providers have accelerated the adoption of domestic manufacturing partnerships and vetted alternative raw material sources. This strategic pivot not only offsets tariff burdens but also enhances supply chain resilience. In parallel, organizations have intensified their focus on lean laboratory principles, adopting modular instrumentation architectures and reagent pooling strategies to optimize resource utilization and contain costs without compromising performance.

The cumulative financial impact of the new tariff regime has also spurred dialogue between service providers, payer groups, and accreditation bodies regarding acceptable price adjustments and reimbursement frameworks. Stakeholders are exploring value-based contracting models that align reimbursement with demonstrable clinical outcomes, thereby cushioning laboratories against unsustainable price inflations. These collaborative efforts highlight the sector's capacity for adaptive resilience, as laboratories and service partners coalesce around innovative procurement and pricing mechanisms to ensure continuity of critical testing operations.

Revealing Insightful Key Segmentation Trends in Healthcare Analytical Testing Across Testing Types Technologies Samples Applications and End Users

Healthcare analytical testing can be understood through the prism of testing type, where qualitative services encompass spot tests designed for rapid visual or colorimetric responses alongside detailed visual inspection protocols that confirm sample integrity. In contrast, quantitative offerings rely on immunoassays to quantify biomarkers with high specificity and on instrumental analysis techniques that leverage spectroscopic signals and mass-to-charge ratios to deliver precise concentration measurements. This dual approach ensures both immediate screening capabilities and in-depth quantitative validation.

Examining the market through the lens of technology reveals an array of platforms, starting with chromatographic separation that differentiates analytes based on chemical properties and advances through gas and liquid chromatography modalities to achieve high-resolution results. Mass spectrometry further refines identification and quantitation by coupling gas chromatography with mass detectors, liquid chromatography with tandem mass spectrometry, or leveraging matrix-assisted laser desorption ionization for rapid profiling. Microscopy, polymerase chain reaction, and various spectroscopic techniques complement these core technologies, enabling multi-parameter analyses across diverse biological matrices.

Diverse sample types shape the testing workflow, with blood samples offering plasma, serum, or whole blood fractions to address immunological, metabolic, and hematological inquiries. Tissue biopsies and urine specimens provide insights into localized pathology and renal or metabolic function, respectively. Application-based segmentation underscores the multifaceted utility of analytical testing, spanning genetic sequencing for precision oncology, infectious disease panels for public health surveillance, forensic analysis for toxicology and DNA profiling, and stringent bioanalytical and quality control assays within pharmaceutical development.

End users range from research-focused academic and university laboratories to contract research organizations that offer specialized testing services. Hospital and pathology labs deliver critical diagnostic support in clinical settings, while pharmaceutical and biotechnology companies integrate analytical testing into drug discovery, formulation, and stability studies. This segmentation framework illuminates tailored service offerings, enabling stakeholders to align capabilities with distinct market needs and regulatory requirements.

Presenting Key Regional Insights into Healthcare Analytical Testing Market Variations Across the Americas Europe Middle East Africa and Asia Pacific

Regional dynamics play a pivotal role in shaping the global healthcare analytical testing landscape, as evolving regulatory frameworks, infrastructure capabilities, and investment patterns differ significantly across territories. In the Americas, established markets continue to refine reimbursement policies and incentivize the adoption of advanced diagnostic platforms, while emerging economies in Latin America are prioritizing laboratory capacity expansion and skill development to strengthen public health surveillance networks.

Across Europe, the Middle East, and Africa, regulatory harmonization efforts are accelerating the mutual recognition of testing standards, enabling cross-border collaboration and streamlining market entry for innovative assays. Investments in centralized reference laboratories and proficiency testing schemes are enhancing quality assurance, particularly in regions where decentralized sample collection must interface with urban testing hubs. Infrastructure upgrades, supported by public-private partnerships, are fostering the deployment of point-of-care testing and mobile laboratories to address remote populations.

The Asia-Pacific region continues to experience robust growth in analytical testing demand, driven by expanding biopharmaceutical research ecosystems, large-scale disease screening initiatives, and private sector laboratory consolidations. Government-led mandates are spurring capacity augmentation in metropolitan areas, while manufacturing clusters in key countries support the regional supply chain for instrumentation and consumables. Collaborative research consortia and cross-border knowledge sharing are further reinforcing quality standards and accelerating method development for emerging health threats.

These regional insights underscore the importance of adaptive strategies that respect local regulatory nuances, infrastructure readiness, and public health priorities. Service providers and equipment vendors must calibrate their offerings to align with the unique requirements of each region, fostering partnerships that address both urban centers of excellence and underserved populations.

Highlighting Strategic Movements and Competitive Landscapes of Leading Companies Driving Innovation in Healthcare Analytical Testing Services Globally

The competitive arena of healthcare analytical testing services is defined by a cohort of established laboratories, innovative service providers, and specialized technology vendors. Leading organizations are leveraging comprehensive service portfolios that integrate high-throughput screening, advanced bioinformatics, and customized assay development to differentiate themselves. Strategic investments in proprietary reagent kits, laboratory automation, and digital data platforms are enabling these pioneers to offer standardized yet flexible solutions that cater to a broad spectrum of clinical and research applications.

Mid-tier players are carving niches by focusing on specialized testing verticals such as rare disease panels, companion diagnostics, or forensic toxicology. These providers often form strategic alliances with academic institutions and biotechnology firms to co-develop assays and validate novel biomarkers. By concentrating on high-value testing segments, they are building reputational capital and fostering client loyalty through rapid turnaround times and dedicated technical support.

Emerging entrants, including digital health startups and specialty reagent manufacturers, are disrupting legacy models by introducing microfluidics-based point-of-care devices, AI-driven assay interpretation tools, and continuous monitoring platforms. These innovators are forging partnerships with traditional laboratories to integrate new capabilities, thereby accelerating adoption curves and expanding service reach. Additionally, several global reagent and consumables suppliers are deepening their service offerings by establishing in-house testing facilities, effectively transforming from product vendors to end-to-end service providers.

Competitive differentiation increasingly hinges on the ability to demonstrate value through data transparency, collaborative research frameworks, and flexible pricing constructs. As competitive pressures intensify, service providers that can seamlessly integrate advanced technologies, uphold rigorous quality standards, and foster collaborative ecosystems will emerge as industry frontrunners.

Providing Actionable Recommendations for Industry Leaders to Enhance Competitiveness and Drive Growth in Healthcare Analytical Testing Services

Industry leaders must prioritize investments in digital transformation to maintain competitive advantage and operational efficiency. Integrating cloud-based data management, artificial intelligence-enhanced analytics, and remote monitoring capabilities can drastically reduce turnaround times, enhance traceability, and support scalable laboratory networks. Cultivating partnerships with software developers and bioinformatics specialists will ensure that emerging technologies are seamlessly incorporated into existing workflows.

Laboratories and service providers should evaluate opportunities to diversify their reagent and consumables portfolio by establishing strategic sourcing agreements with multiple suppliers. This dual-sourcing strategy not only mitigates supply chain disruptions associated with trade tensions and regulatory changes but also fosters competitive pricing dynamics. Concurrently, organizations should conduct periodic spend analyses and lean process audits to eliminate waste, optimize reagent utilization, and enhance resource allocation across test volumes and types.

To navigate the evolving tariff landscape and reimbursement environment, stakeholders are advised to engage proactively with policymakers, payer groups, and accreditation bodies. Collaborative forums and value-based contracting frameworks can facilitate transparent dialogue on cost drivers, clinical outcomes, and mutual value creation. By aligning service pricing with demonstrable patient benefits and health economic outcomes, laboratories can secure sustainable reimbursement pathways and mitigate margin pressures.

Finally, fostering a culture of continuous learning and technical excellence remains imperative. Structured training programs, proficiency testing initiatives, and cross-functional knowledge exchanges will equip laboratory personnel and management teams to adapt swiftly to new analytical methods and regulatory guidelines. These actionable measures will position industry leaders to drive innovation, optimize profitability, and deliver superior testing services in a rapidly evolving healthcare landscape.

Detailing the Rigorous Research Methodology Employed for Comprehensive Analysis of Healthcare Analytical Testing Service Trends and Market Drivers

The research foundation for this analysis was established through a systematic multi-stage approach encompassing primary and secondary data acquisition, rigorous validation protocols, and expert consultations. Initially, an extensive literature review of peer-reviewed journals, regulatory guidelines, and industry white papers was conducted to map foundational trends and identify emerging technologies. This secondary research phase laid the groundwork for hypothesis generation and framework development.

Primary data collection involved in-depth interviews with a cross-section of industry stakeholders, including laboratory directors, technology vendors, regulatory specialists, and procurement managers. These conversations provided real-world insights into operational challenges, investment decision drivers, and strategic priorities. Additionally, surveys administered to service providers captured quantitative metrics related to technology adoption rates, capacity utilization, and cost management practices.

All collected data underwent a multi-tiered validation process, involving triangulation across sources, statistical consistency checks, and peer reviews by subject matter experts. Market intelligence tools were leveraged to analyze trade flows, tariff schedules, and regional infrastructure investments. The synthesis of qualitative narratives with quantitative indicators enabled the construction of a robust analytical model capable of delineating market dynamics and projecting strategic imperatives.

This rigorous methodology ensures that the findings presented herein are grounded in accurate, up-to-date evidence and reflect the nuanced realities of the healthcare analytical testing services sector. Stakeholders can thus engage with the insights confidently, knowing they are supported by a comprehensive and transparent research framework.

Synthesizing Critical Findings and Strategic Imperatives for Stakeholders Navigating the Evolving Healthcare Analytical Testing Services Environment

The confluence of technological innovation, regulatory evolution, and shifting economic pressures is reshaping the healthcare analytical testing services landscape. Stakeholders equipped with a clear understanding of transformative shifts-from advanced instrumentation adoption to the digitalization of data workflows-are positioned to capitalize on emerging opportunities and navigate market complexities. The 2025 tariff adjustments underscore the importance of resilient supply chains and collaborative procurement strategies to mitigate cost fluctuations and sustain margin integrity.

Segmentation insights reveal the critical interplay between qualitative and quantitative testing modalities, diversified technology platforms, and application-specific requirements across end users. Regional nuances further emphasize the need for tailored strategies that respect local regulatory frameworks while leveraging global best practices. Competitive dynamics highlight the rise of niche specialists and technology disruptors, reinforcing the imperative for continuous innovation and strategic partnerships.

By synthesizing these findings into actionable recommendations, industry leaders can prioritize investments in digital transformation, lean laboratory practices, and stakeholder engagement forums. This holistic perspective equips decision-makers with the tools to enhance operational efficiency, foster sustainable growth, and deliver high-value testing services that align with evolving clinical and research imperatives.

Ultimately, the insights presented in this summary will serve as a strategic compass, guiding laboratories, service providers, and technology partners toward informed decisions that drive long-term resilience and market leadership.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Integration of artificial intelligence and machine learning algorithms in clinical diagnostic testing to enhance accuracy and speed
  • 5.2. Adoption of point of care testing devices integrated with digital health ecosystems for real time patient monitoring
  • 5.3. Growth of personalized medicine driving demand for high throughput genomic and proteomic testing platforms
  • 5.4. Increasing regulatory emphasis on 21 CFR Part 11 compliance in laboratory information management systems
  • 5.5. Rising investment in metabolomics profiling for early disease biomarker discovery and preventive healthcare strategies
  • 5.6. Expansion of contract development and manufacturing organizations offering end to end analytical method development services
  • 5.7. Implementation of blockchain technology to ensure secure traceability of clinical trial samples and test results
  • 5.8. Surge in adoption of mass spectrometry imaging for spatial metabolomics and biomarker localization in tissue analysis
  • 5.9. Demand for multiomics data integration platforms to provide comprehensive insights across genomics proteomics and metabolomics datasets
  • 5.10. Focus on sustainability with development of green chemistry analytical methods to reduce hazardous reagent consumption

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Healthcare Analytical Testing Services Market, by Testing Type

  • 8.1. Introduction
  • 8.2. Qualitative
    • 8.2.1. Spot Tests
    • 8.2.2. Visual Inspection
  • 8.3. Quantitative
    • 8.3.1. Immunoassays
    • 8.3.2. Instrumental Analysis

9. Healthcare Analytical Testing Services Market, by Technology Type

  • 9.1. Introduction
  • 9.2. Chromatography
    • 9.2.1. Gas Chromatography
    • 9.2.2. Liquid Chromatography
  • 9.3. Mass Spectrometry
    • 9.3.1. GC MS
    • 9.3.2. LC MS MS
    • 9.3.3. MALDI TOF
  • 9.4. Microscopy
  • 9.5. PCR
  • 9.6. Spectroscopy

10. Healthcare Analytical Testing Services Market, by Sample Type

  • 10.1. Introduction
  • 10.2. Blood
    • 10.2.1. Plasma
    • 10.2.2. Serum
    • 10.2.3. Whole Blood
  • 10.3. Tissue
  • 10.4. Urine

11. Healthcare Analytical Testing Services Market, by Application

  • 11.1. Introduction
  • 11.2. Clinical Diagnostics
    • 11.2.1. Genetic Testing
    • 11.2.2. Infectious Disease
    • 11.2.3. Oncology Markers
  • 11.3. Forensics Testing
    • 11.3.1. DNA Profiling
    • 11.3.2. Toxicology
  • 11.4. Pharmaceutical Testing
    • 11.4.1. Bioanalytical Testing
    • 11.4.2. Quality Control

12. Healthcare Analytical Testing Services Market, by End-User

  • 12.1. Introduction
  • 12.2. Academic & Research Institutes
    • 12.2.1. Research Institutes
    • 12.2.2. Universities
  • 12.3. Contract Research Organizations
  • 12.4. Hospitals & Clinics
    • 12.4.1. Hospital Labs
    • 12.4.2. Pathology Labs
  • 12.5. Pharmaceutical & Biotechnology Companies

13. Americas Healthcare Analytical Testing Services Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Healthcare Analytical Testing Services Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Healthcare Analytical Testing Services Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Eurofins Scientific SE
    • 16.3.2. Laboratory Corporation of America Holdings
    • 16.3.3. Almac Group Limited
    • 16.3.4. ALS Limited
    • 16.3.5. Catalent, Inc.
    • 16.3.6. CD Biosciences Inc.
    • 16.3.7. Charles River Laboratories International, Inc.
    • 16.3.8. Element Materials Technology Group Limited
    • 16.3.9. Frontage Laboratories, Inc. by Tigermed
    • 16.3.10. ICON PLC
    • 16.3.11. Intertek Group PLC
    • 16.3.12. IQVIA Holdings Inc.
    • 16.3.13. Medpace, Inc.
    • 16.3.14. Pace Analytical Services, LLC
    • 16.3.15. Pharmaron
    • 16.3.16. Piramal Pharma Solutions
    • 16.3.17. PPD, Inc.
    • 16.3.18. Quest Diagnostics Incorporated
    • 16.3.19. Reading Scientific Services Ltd.
    • 16.3.20. Sartorius AG
    • 16.3.21. SGS SA
    • 16.3.22. Thermo Fisher Scientific Inc.
    • 16.3.23. WuXi AppTec Co., Ltd.

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RESEARCHAI
  • FIGURE 26. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RESEARCHSTATISTICS
  • FIGURE 27. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RESEARCHCONTACTS
  • FIGURE 28. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SPOT TESTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SPOT TESTS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY VISUAL INSPECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY VISUAL INSPECTION, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY INSTRUMENTAL ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY INSTRUMENTAL ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GC MS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GC MS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY LC MS MS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY LC MS MS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MALDI TOF, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MALDI TOF, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MICROSCOPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SPECTROSCOPY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 65. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 67. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 69. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 71. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 73. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 75. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 77. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY MARKERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ONCOLOGY MARKERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 79. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 81. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 83. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY DNA PROFILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY DNA PROFILING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 85. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 87. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 89. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 91. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 93. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 95. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 97. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 99. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 101. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 103. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 105. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 107. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 109. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 111. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITAL LABS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 113. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 115. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 117. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 119. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 121. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 123. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 125. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 127. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 129. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 131. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 133. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 135. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 137. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 139. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 141. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 143. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 145. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 147. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 148. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 149. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. AMERICAS HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 165. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 166. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 167. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 168. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 169. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 170. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 171. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 172. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 173. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 174. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 175. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 176. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 177. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 178. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 179. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 180. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 181. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 182. UNITED STATES HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 183. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 185. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 186. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 187. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 188. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 189. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 191. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 192. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 193. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 194. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 195. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 197. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 198. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 199. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 201. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 202. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 203. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 204. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 205. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 206. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 207. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 208. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 209. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 210. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 211. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 212. CANADA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 213. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 215. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 216. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 217. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 218. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 219. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 221. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 222. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 223. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 224. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 225. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 227. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 228. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 229. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 231. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 232. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 233. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 234. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 235. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 236. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 237. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 238. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 239. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 240. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 241. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 242. MEXICO HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 243. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 245. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 246. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 247. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 248. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 249. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 251. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 252. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMATOGRAPHY, 2025-2030 (USD MILLION)
  • TABLE 253. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2018-2024 (USD MILLION)
  • TABLE 254. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY MASS SPECTROMETRY, 2025-2030 (USD MILLION)
  • TABLE 255. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
  • TABLE 257. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
  • TABLE 258. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
  • TABLE 259. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 261. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 262. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
  • TABLE 263. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2018-2024 (USD MILLION)
  • TABLE 264. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY FORENSICS TESTING, 2025-2030 (USD MILLION)
  • TABLE 265. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2018-2024 (USD MILLION)
  • TABLE 266. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL TESTING, 2025-2030 (USD MILLION)
  • TABLE 267. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 268. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
  • TABLE 269. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2024 (USD MILLION)
  • TABLE 270. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2025-2030 (USD MILLION)
  • TABLE 271. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
  • TABLE 272. BRAZIL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
  • TABLE 273. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
  • TABLE 275. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2018-2024 (USD MILLION)
  • TABLE 276. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUALITATIVE, 2025-2030 (USD MILLION)
  • TABLE 277. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2018-2024 (USD MILLION)
  • TABLE 278. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY QUANTITATIVE, 2025-2030 (USD MILLION)
  • TABLE 279. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
  • TABLE 280. ARGENTINA HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
  • TABLE 281. ARGENTINA HEALTH